James Hardie Industries PLC lower as the Materials sector gains on the day
Here is the latest company close update for James Hardie Industries PLC, JHX.
Here is the latest company close update for James Hardie Industries PLC, JHX.
HealthCo’s record jump after HMC Capital defers Healthscope rents. Big payouts for AZEK executives in controversial James Hardie buyout. Sigma’s best days ‘behind it’. Trump team plots Plan B on tariffs.
Investors boost bourse after RBA’s second rate cut this year. CBA powers to new record. Environment Minister Murray Watt says Woodside extension call coming by end of month. Nufarm tanks. Westpac job cuts may boost profits by $725m.
The building products giant remains under attack from shareholders over its $14bn deal to buy US rival Azek, amid concern new governance pledges may fail to placate investors.
A costly acquisition has exposed bigger tensions in the running of a company that left Australia years ago.
The $14bn buyout plan of Azek in a precursor to a US listing appears to have backfired for directors of the iconic Aussie company.
Lynas talks up opportunity in China-US fight. Bega preps for Fonterra deal. James Hardie allays governance concerns. Tariff impacts weigh on Flight Centre, Brambles. Telix down on FDA blow.
ASX boss Helen Lofthouse says the market operator has listened to the concerns of aggrieved James Hardie shareholders over the company’s pursuit of Azek and a US listing.
ASIC should consider whether ASX’s actions in relation to both James Hardie and any other waivers it has allowed were detrimental to shareholders.
The ASX leans into the letter of the law rather than its ‘moral principals’ as the unpopular James Hardie deal unites investment minds like never before.
In an unprecedented move, Australia’s biggest fund managers have protested against the ASX ushering in the $14bn James Hardie-Azek merger without scrutiny.
An unprecedented protest by top fund managers is targeting ASX governance and transparency amid the $14bn listed company takeover.
After the asbestos scandal, building materials giant James Hardie is in hot water again, this time with shareholders who have been frozen out of a controversial takeover of US rival Azek.
Vulcan’s European tick triggers investor rush while Jeanswest goes in administration again. Paladin shares sinks as rain washes away guidance, Whyalla interest boosts BlueScope and rate cut hopes up on Feb inflation fall.
James Hardie’s move to a primary listing in the US has revived the debate about where the future lies for Australian stocks such as Woodside Energy.
James Hardie’s $14bn buyout proposal for fellow building materials company Azek has created an investor firestorm in Australia and the US.
WA miner Gold Road hits record amid standoff with rejected suitor, partner Gold Fields. Regal in recovery mode as Opthea questions remain. James Hardie stays in the red after analyst ratings changes. Budget to reveal worsening debt outlook.
James Hardie is betting it all to hitch itself to a new growth business. The test is whether the combination can prove to be more valuable than going it alone.
James Hardie has become the latest Australian listed company to face the wrath of investors over a big acquisition.
James Hardie boss Aaron Erter has shrugged off concerns over the timing of its massive $14bn Azek deal, saying the companies perform well ‘no matter what’s going on’.
Building products giant James Hardie’s likely paying too much for US buy. Potential loss of CBA contract hits Helia. Regal dives as pharma group Opthea enters suspension amid survival talks.
Facing headwinds in Australia, James Hardie bets on US growth and material conversion strategies to drive future earnings as it watches for US tariffs.
SA govt puts Whyalla Steelworks into administration. NAB shares slumps as margin strain dents earnings. MinRes tanks on massive loss. Santos results disappoint. WA rich lister sells $8.5bn Rio stake. MinRes’ big loss triggers double-digit dive. Profitable Goodman taps investors for $4bn.
James Hardie’s delay in restarting its share buyback program has many tipping that the $24bn Australian-listed building materials powerhouse has acquisitions on its agenda.
Macquarie Group is thought to be working on two equity raisings to be announced this week, one of which could involve building products giant James Hardie and its acquisition strategy.
Building products group James Hardie has lifted its full-year guidance following a better-than-expected second quarter.
ASIC warns of broader Cbus-like issues as super gint agrees to Senate hearing. Johns Lyng gets second strike. MinRes to mothball WA mine, 300 jobs impacted. Nuix sinks 20pc-plus despite CEO assurance. WiseTech hit with class action.
Market updates from some of Australia’s top industrial stocks could be weighing on the share price of building materials provider James Hardie.
Wages growth at its slowest pace in two years, but no rate cut yet. CSL’s FY25 guidance disappoints. Orora rejects Lone Star’s ‘opportunistic’ $4.3bn offer. Seek dives after swing to loss. Temple & Webster soars on trading update.
In a subdued session, Tuesday’s trading gave back a portion of Monday’s rally.
Original URL: https://www.theaustralian.com.au/topics/james-hardie